1-{(S)-3-[3-(4-Chloro-phenoxy)-azetidin-1-yl]-1-hydroxymethyl-propyl}-3-(5-ethyl-2-methyl-2H-pyrazol-3-yl)-urea → 1-{(S)-3-[3-(3,4-dichloro-phenoxy)-azetidin-1-yl]-1-hydroxymethyl-propyl}-3-(5-ethyl-2-methyl-2H-pyrazol-3-yl)-urea
反応式
[Cl:1][C:2]1[CH:29]=[CH:28][C:5]([O:6][CH:7]2[CH2:10][N:9]([CH2:11][CH2:12][C@H:13]([NH:16][C:17]([NH:19][C:20]3[N:21]([CH3:27])[N:22]=[C:23]([CH2:25][CH3:26])[CH:24]=3)=[O:18])[CH2:14][OH:15])[CH2:8]2)=[CH:4][CH:3]=1.Cl.N[C@@H](CCN1CC(OC2C=CC([Cl:48])=C(Cl)C=2)C1)CO>>[Cl:48][C:29]1[CH:28]=[C:5]([CH:4]=[CH:3][C:2]=1[Cl:1])[O:6][CH:7]1[CH2:8][N:9]([CH2:11][CH2:12][C@H:13]([NH:16][C:17]([NH:19][C:20]2[N:21]([CH3:27])[N:22]=[C:23]([CH2:25][CH3:26])[CH:24]=2)=[O:18])[CH2:14][OH:15])[CH2:10]1参加物
3
反応物 2
生成物 1
実験手順
This compound is prepared in a manner analogous to that used to prepare 1-{(S)-3-[3-(4-chloro-phenoxy)-azetidin-1-yl]-1-hydroxymethyl-propyl}-3-(5-ethyl-2-methyl-2H-pyrazol-3-yl)-urea in Example 88 except using (S)-2-amino-4-[3-(3,4-dichloro-phenoxy)-azetidin-1-yl]-butan-1-ol hydrochloride in place of (S)-2-amino-4-[3-(4-chloro-phenoxy)-azetidin-1-yl]-butan-1-ol hydrochloride.
後処理
- customThis compound is prepared in a manner analogous to
出典と根拠
- ORDレコード
- ord-989baf9492e9441196f8d305559bd2ec
- 出典データセット
- uspto-grants-2007_10
- 特許番号
- US07288537B2
反応ノート
読み込み中…